HB 1418: Drug Price Transparency

HB 1418: Drug Price Transparency

Relative to Transparency and Cost Control Of Pharmaceutical Drug Prices.

New Futures supports this bill, as it creates a commission which would look at drug price transparency and rebates for pharmaceutical benefit managers. New Futures supports this bill because it would shine a light on the costs of drugs so that the state and, in turn, the public can better understand the increasing costs of pharmaceuticals.

Click here for bill text.

This bill was voted 'Ought to Pass" by both the NH House and Senate.

Bill Status
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote